Sex and gender differences in comorbidities in spondyloarthritis: a focus on psoriatic arthritis.

In conclusion, our review suggests that the evaluation of sex-gender aspects of CV comorbidities in PsA should be a central step in the context of personalized medicine in order to prevent and treat properly associated comorbidities.